These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26756763)

  • 1. Targeted Nanotherapies for the Treatment of Surgical Diseases.
    Morgan CE; Wasserman MA; Kibbe MR
    Ann Surg; 2016 May; 263(5):900-7. PubMed ID: 26756763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotherapeutics in the EU: an overview on current state and future directions.
    Hafner A; Lovrić J; Lakoš GP; Pepić I
    Int J Nanomedicine; 2014; 9():1005-23. PubMed ID: 24600222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics.
    Korin N; Gounis MJ; Wakhloo AK; Ingber DE
    JAMA Neurol; 2015 Jan; 72(1):119-22. PubMed ID: 25365638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active drug targeting: lessons learned and new things to consider.
    Al-Jamal KT
    Int J Pharm; 2013 Sep; 454(1):525-6. PubMed ID: 23558315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future of nanotherapeutics: Targeting the cellular sub-organelles.
    Ma X; Gong N; Zhong L; Sun J; Liang XJ
    Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotherapeutic approaches for brain cancer management.
    Saenz del Burgo L; Hernández RM; Orive G; Pedraz JL
    Nanomedicine; 2014 Jul; 10(5):905-19. PubMed ID: 24135564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Nanoparticles and Their Targeted Delivery Applications.
    Yetisgin AA; Cetinel S; Zuvin M; Kosar A; Kutlu O
    Molecules; 2020 May; 25(9):. PubMed ID: 32397080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology and site-targeted drug delivery.
    Petrak K
    J Biomater Sci Polym Ed; 2006; 17(11):1209-19. PubMed ID: 17176746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in ligand targeted therapy.
    Trapani G; Denora N; Trapani A; Laquintana V
    J Drug Target; 2012 Jan; 20(1):1-22. PubMed ID: 21942529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.
    Fazil M; Shadab ; Baboota S; Sahni JK; Ali J
    J Drug Target; 2012 Feb; 20(2):97-113. PubMed ID: 22023651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnological selection.
    Demming A
    Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards more effective advanced drug delivery systems.
    Crommelin DJ; Florence AT
    Int J Pharm; 2013 Sep; 454(1):496-511. PubMed ID: 23415662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics.
    Ziemys A; Klemm S; Milosevic M; Yokoi K; Ferrari M; Kojic M
    Drug Deliv; 2016 Sep; 23(7):2524-2531. PubMed ID: 25835222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.